The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Clinical trial NCT00799903 · COMPLETED

Trial details

NCT number: NCT00799903
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2008-12-01
Primary completion: 2013-10-01
Enrollment: 15828

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.